Most popular HRT 'nearly trebles risk of breast cancer'

Women taking combined oestrogen-progestogen treatment more likely to develop illness, says Institute of Cancer Research

Doctors look at films of breast cancer X-rays
(Image credit: Justin Sullivan/Getty Images)

A major new study claims women who take the most commonly used form of hormone replacement therapy (HRT) are nearly three times more likely to develop breast cancer than those who do not.

The Institute of Cancer Research looked at six years of data for 39,000 menopausal women, of whom 775 had developed the illness. It found those taking combined oestrogen-progestogen HRT – the most popular form – were 2.74 times more likely to develop breast cancer than those not using any HRT at all.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us